Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,044 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $287.15 | 13 | $0 (2021) |
| Shire North American Group Inc | $233.91 | 15 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $194.72 | 7 | $0 (2019) |
| Kala Pharmaceuticals, Inc. | $93.77 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $93.13 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $55.91 | 3 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $33.15 | 2 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $21.28 | 1 | $0 (2022) |
| ABBVIE INC. | $19.89 | 1 | $0 (2022) |
| TissueTech, Inc. | $11.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.13 | 1 | Astellas Pharma US Inc ($93.13) |
| 2022 | $41.17 | 2 | Bausch & Lomb Americas Inc. ($21.28) |
| 2021 | $38.44 | 2 | Novartis Pharmaceuticals Corporation ($21.97) |
| 2020 | $108.16 | 2 | Kala Pharmaceuticals, Inc. ($93.77) |
| 2019 | $127.25 | 7 | Allergan Inc. ($65.98) |
| 2018 | $591.82 | 29 | Allergan Inc. ($190.31) |
| 2017 | $44.39 | 2 | Shire North American Group Inc ($44.39) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $93.13 | General |
| Category: Ophthalmology | ||||||
| 08/26/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/13/2022 | Bausch & Lomb Americas Inc. | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Ophthalmology | ||||||
| 11/16/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/06/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: GLAUCOMA | ||||||
| 03/13/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: DRY EYE | ||||||
| 03/10/2020 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $93.77 | General |
| Category: OCULAR | ||||||
| 10/22/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $11.20 | General |
| Category: Ophthalmology | ||||||
| 10/08/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/30/2019 | Allergan Inc. | ALPHAGAN P (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/11/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/04/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/03/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/09/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: OPTHALMICS | ||||||
| 12/19/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/19/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/18/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: OPTHALMICS | ||||||
| 11/01/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $83.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/09/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 338 | 367 | $123,471 | $24,297 |
| 2022 | 8 | 898 | 1,101 | $231,771 | $55,361 |
| 2021 | 6 | 929 | 1,137 | $237,342 | $59,059 |
| 2020 | 7 | 1,136 | 1,343 | $289,622 | $72,144 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92004 | New patient complete exam of visual system | Office | 2023 | 73 | 73 | $20,805 | $7,019 | 33.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 77 | 77 | $18,785 | $5,761 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 84 | $27,240 | $4,945 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 21 | $10,290 | $1,780 | 17.3% |
| 92134 | Imaging of retina | Office | 2023 | 47 | 54 | $19,476 | $1,538 | 7.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $7,920 | $1,285 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $7,275 | $1,168 | 16.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 27 | 32 | $11,680 | $801.02 | 6.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 297 | 326 | $98,126 | $24,109 | 24.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 211 | 292 | $64,824 | $15,754 | 24.3% |
| 92134 | Imaging of retina | Office | 2022 | 161 | 217 | $25,606 | $5,584 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 59 | $10,030 | $3,485 | 34.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 100 | 119 | $13,685 | $2,748 | 20.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 58 | 61 | $13,054 | $2,365 | 18.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 13 | 13 | $5,018 | $914.68 | 18.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 14 | $1,428 | $401.98 | 28.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 317 | 347 | $104,447 | $26,874 | 25.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 221 | 299 | $66,378 | $16,909 | 25.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 179 | 245 | $28,910 | $6,469 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 56 | $9,520 | $3,188 | 33.5% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 102 | 127 | $14,605 | $2,836 | 19.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 60 | 63 | $13,482 | $2,783 | 20.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 432 | 477 | $132,709 | $38,115 | 28.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 232 | 313 | $60,686 | $18,075 | 29.8% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 228 | 276 | $47,758 | $7,760 | 16.2% |
About Dr. Jason Schad, O.D
Dr. Jason Schad, O.D is a Optometrist healthcare provider based in Hartford, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1194109876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Schad, O.D has received a total of $1,044 in payments from pharmaceutical and medical device companies, with $93.13 received in 2024. These payments were reported across 45 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,044).
As a Medicare-enrolled provider, Schad has provided services to 3,301 Medicare beneficiaries, totaling 3,948 services with total Medicare billing of $210,861. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Hartford, WI
- Active Since 07/13/2015
- Last Updated 10/24/2024
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1194109876
Products in Payments
- XIIDRA (Drug) $255.88
- LUMIGAN (Drug) $160.92
- VYZULTA (Drug) $142.16
- INVELTYS (Drug) $93.77
- Izervay (Drug) $93.13
- COMBIGAN (Drug) $73.86
- BESIVANCE (Drug) $29.30
- PROLENSA (Drug) $23.26
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $21.95
- ALPHAGAN P (Drug) $21.51
- LOTEMAX SM (Drug) $21.28
- VUITY (Drug) $19.89
- TRAVATAN Z (Drug) $18.26
- DURYSTA (Drug) $16.47
- DUREZOL (Drug) $15.68
- RESTASIS (Drug) $14.39
- Prokera (Device) $11.45
- CEQUA (Drug) $11.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Hartford
Dr. Michelle Kwon, O.d, O.D
Optometrist — Payments: $15,477
Dr. Barbara Dune, O.d, O.D
Optometrist — Payments: $12,836
Dr. John Nedelcu, O.d, O.D
Optometrist — Payments: $4,076
Hessam Vaziri
Optometrist — Payments: $3,384
Dr. Lauren Colite, O.d, O.D
Optometrist — Payments: $2,773
Dr. Alireza Jabbari, O.d, O.D
Optometrist — Payments: $2,174